Clinical Trials

    Showing 1 - 3 of 3 Cardiac Arrest

    A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Amyloid Depleter ALXN2220 in Adult Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

    Status: Open Not Enrolling

    Investigator: Mahwash Kassi

    Study Coordinator: Jan-Michael Ragunton

    Phone: 346.238.0218

    NCT06183931 The primary objective of this study is to access the efficacy of ALXN2220 in the treatment of adult participants with ATTR-CM by evaluating the difference between the ALXN2220 and placebo groups as assessed by the total occurrences of al... Read more >

    Pulmonary Artery DenerVation Clinical Study using the Gradient Denervation System in Heart Failure Patients with Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

    Status: Enrolling

    Investigator: Rayan Yousefzai

    Study Coordinator: Jan-Michael Ragunton

    Phone: 346.238.0218

    Characterize the impact of pulmonary artery denervation on the quality of life in Heart Failure Patients with Group 2 Pulmonary Hypertension... Read more >

    US National OCS Heart Perfusion (OHP) Registry

    Status: Enrolling

    Investigator: Mehmet Akay

    Study Coordinator: Jan-Michael Ragunton

    Phone: 346.238.0218

    The objective of this US National OHP Registry is to collect data on the post-transplant clinical outcomes of all donor hearts preserved and assessed on the OCS Heart System and to document the performance of the OCS Heart device in the real-world se... Read more >